Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Specialty Devices
Diabetes Care Devices
Return to: MDBR Home | Specialty Devices | Diabetes Care Devices

Diabetes Care Devices

Intuity Medical increases series 3 funding to $55m Intuity Medical, a privately-held company developing innovative technologies for diabetes management, announced that it has closed an additional $15 million, which brings the total Series 3 equity financing for the company to $55m.
Specialty Devices > Diabetes Care Devices > News
Health Canada approves Ascensia's Contour Next One blood glucose monitoring system By MDBR Staff Writer
Ascensia Diabetes Care has received approval from Health Canada for its Contour Next One blood glucose monitoring system (BGMS).
Specialty Devices > Diabetes Care Devices > News Animas’ OneTouch Vibe Plus insulin pump gets FDA approval and Health Canada license By MDBR Staff Writer
Animas, part of the Johnson & Johnson Diabetes Care Companies (JJDCC), has secured the US Food and Drug Administration (FDA) approval and Health Canada' license to market the OneTouch Vibe Plus insulin pump and continuous glucose monitoring (CGM) system.
Specialty Devices > Diabetes Care Devices > News
See more Diabetes Care Devices news

Latest Diabetes Care Devices News and Insight

View all Diabetes Care Devices news or find news targeted to your interests
Glytec announced another notice of allowance for its precision diabetes management technologies
Glytec announces another notice of allowance from the United States Patent and Trademark Office (USPTO) for its eGlycemic Management System (eGMS), a modularized software-as-a-service solution used by hospitals and health systems for personalized insulin dosing, enterprise glucose surveillance, performance-driven analytics, and more.
Specialty Devices > Diabetes Care Devices > News
GI Dynamics announces launch of security purchase plan
GI Dynamics announce that it has received commitments for a private placement of 69,865,000 fully paid CHESS Depositary Interests (CDIs) of the Company (representing 1,397,300 shares of common stock) at an issue price of A$0.022 per CDI to sophisticated and professional investors in Australia and certain other jurisdictions to raise approximately A$1.5 million (Placement).
Specialty Devices > Diabetes Care Devices > News
Defymed, Semma Therapeutics partner to develop solution for treating type-1 diabetes
By MDBR Staff Writer
Biotech firms Defymed and Semma Therapeutics have partnered to develop a new solution to treat patients with type-1 diabetes.
Specialty Devices > Diabetes Care Devices > News
Medtronic, Fitbit partner to integrate health and activity data into new CGM solution for type 2 diabetes management
Medtronic and Fitbit have announced a partnership to integrate health and activity tracking for patients living with diabetes and their physicians and care teams.
Specialty Devices > Diabetes Care Devices > News
One Drop | Chrome glucose monitoring system wins CE mark and FDA approval
By MDBR Staff Writer
Digital health firm One Drop has secured the US Food and Drug Administration’s (FDA) 510(k) clearance and CE mark approval in Europe for its new glucose monitoring system.
Specialty Devices > Diabetes Care Devices > News
Voluntis secures approvals in US and EU for Type 2 diabetes management solution
By MDBR Staff Writer
Voluntis has secured both FDA clearance and the CE Mark for a type 2 diabetes management solution called Insulia.
Specialty Devices > Diabetes Care Devices > News
Senseonics expands distribution agreement with Roche
Senseonics Holdings announced it has expanded its exclusive distribution agreement with Roche to include all of Europe, the Middle East and Africa (EMEA), excluding Scandinavia, Finland and Israel.
Specialty Devices > Diabetes Care Devices > News
West expands contract manufacturing capabilities in Ireland
West Pharmaceutical Services, a global leader in innovative solutions for injectable drug administration, announced the completion of a 60,000 square foot expansion at its contract manufacturing facility near Mulhuddart, County Dublin.
Specialty Devices > Diabetes Care Devices > News
View all Diabetes Care Devices news or find news targeted to your interests